1.
Emerg Infect Dis
; 27(2): 628-631, 2021 02.
Artículo
en Inglés
| MEDLINE
| ID: mdl-33496235
RESUMEN
We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.